Ticker
VYNECompany Name
VYNE THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Free Cash Flow | Free Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -39.89M | -8380.25% | $ 476K |
3/31/2025 | $ -37.57M | -6209.59% | $ 605K |
12/31/2024 | $ -34.09M | -6804.19% | $ 501K |
9/30/2024 | $ -30.11M | -6107.51% | $ 493K |
6/30/2024 | $ -26.75M | -5504.53% | $ 486K |
3/31/2024 | $ -27.84M | -6582.74% | $ 423K |
12/31/2023 | $ -25.34M | -5976.65% | $ 424K |
9/30/2023 | $ -24.08M | -6801.98% | $ 354K |
6/30/2023 | $ -26.05M | -6400.98% | $ 407K |
3/31/2023 | $ -24.7M | -6206.78% | $ 398K |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF / Revenues
(=) FCF %
FCF % for VYNE THERAPEUTICS INC is calculated as follows: FCF [ $ -128.23M ] / Revenues [ $ 16.71M ]
(=) FCF % [ -767.55% ]
Minimum
Jun 30, 2025
Maximum
Dec 31, 2021
Average
Median
filtered constituents | 3.18K |
---|---|
min | -58.23% |
max | 68.19% |
average | 7.87% |
median | 7.4% |
std | 19.48% |